Valo Health

AI drug discovery pill machine learning drug targets data

CRO

Charles River and Valo pact nets preclinical lupus asset

The small molecule is an inhibitor designed for an autoimmune target that no other therapies go after.

Darren Incorvaia Mar 26, 2025 6:30am

concept of computer chip and dollar sign

Novo bets $190M near-term on AI pact in obesity, diabetes

Jan 8, 2025 8:00am

eye eyeball eye art

Valo abandons ROCK inhibitor after diabetic retinopathy fail

Jan 2, 2025 9:43am

photo of a paraglider in the foreground with the alps in the background

Flagship-backed biotechs name new leaders—Chutes & Ladders

Nov 15, 2024 8:30am

AI artificial intelligence drug development computational biology machine learning

Lundbeck taps Charles River for AI-enabled neuro drug discovery

Oct 2, 2024 9:21am

heart valentines day valentine puzzle merger MA

Novo Nordisk pays $60M for AI-powered cardio collab with Valo

Sep 25, 2023 10:15am